Characterization of the first carbapenem-resistant Pseudomonas aeruginosa clinical isolate harboring blaSIM-1 from the United States,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Characterization of the first carbapenem-resistant Pseudomonas aeruginosa clinical isolate harboring blaSIM-1 from the United States
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-08-02 , DOI: 10.1128/aac.01066-21
Catharine Prussing ₁ , Theresa Canulla _{2,

3,

4} , Navjot Singh ₁ , Patricia McAuley _{4,

5} , Michael Gosciminski _{4,

5} , Ewa King _{3,

4} , Utpala Bandy _{4,

5} , María-José Machado ₆ , Maria Karlsson ₆ , Kimberlee A Musser ₁ , Richard C Huard _{2,

3,

4} , Elizabeth J Nazarian ₁

Affiliation

The emergence and transmission of metallo-β-lactamases are significant public health concerns that threaten the utility of antimicrobial therapy (1, 2).…

中文翻译：